CCSD Code G1440: Injection Sclerotherapy for Oesophageal Varices

Key Takeaways

CCSD Code G1440 describes Injection Sclerotherapy for Oesophageal Varices, an endoscopic procedure used to treat bleeding oesophageal varices in UK private healthcare.

Recognised UK private insurers including Bupa, AXA Health, Allianz Care UK, and The Exeter use CCSD codes as the standard billing framework. Guernsey’s 2021 published schedule listed G1440 at £1,910.00.

Claims submitted under CCSD Code G1440 require documented clinical indication, procedure notes confirming endoscopic access, and insurer pre-authorisation in most cases.

Pabau’s claims management software helps UK private gastroenterology practices submit CCSD-coded claims accurately and track authorisation status across multiple insurers.

CCSD Code G1440: What It Covers and When to Use It

Billing staff at UK private gastroenterology clinics regularly encounter procedures where one incorrect code can trigger a rejection, a reduced payment, or a request for further documentation. CCSD Code G1440 is one of those codes where precision matters. It describes Injection Sclerotherapy for Oesophageal Varices, a specific endoscopic intervention used to control active or recurrent haemorrhage from varices caused by portal hypertension. Getting it right the first time protects both revenue and clinical documentation integrity.

The CCSD (Coding, Classification and Schedule Development) schedule is the standard coding framework for all UK private healthcare procedure billing. It is administered by Grant Thornton UK LLP, which maintains and updates the schedule on behalf of the private healthcare sector. This guide covers everything a billing team or practice manager needs to know about CCSD Code G1440: the clinical context, applicable insurer fee schedules, documentation standards, and how to avoid common claim errors.

Procedure Description for CCSD Code G1440

Oesophageal varices are dilated submucosal veins in the oesophagus, most commonly arising as a complication of portal hypertension secondary to liver cirrhosis. When these varices rupture, they cause significant upper gastrointestinal haemorrhage that requires urgent intervention. Injection sclerotherapy is an established endoscopic technique for controlling that haemorrhage and preventing recurrence.

During the procedure, a specialist surgeon or gastroenterologist passes a flexible upper GI endoscope into the oesophagus. A sclerosing agent is then injected directly into or adjacent to the variceal vessel, causing thrombosis and fibrosis that obliterates the vein. The technique is performed under direct visualisation, and multiple injection sites may be treated in a single session.

CCSD Code G1440 applies specifically to this procedure. It does not cover:

• Diagnostic upper GI endoscopy alone
• Variceal band ligation (which has its own separate CCSD code)
• Endoscopic mucosal resection of high-grade dysplasia in Barrett’s oesophagus (CCSD Code G1460)
• Rigid oesophagoscopy including biopsy, laser, or diathermy destruction (CCSD Code G1900)
• Oesophageal physiology studies including pH measurement and manometry (CCSD Code G2110)

Accurate identification of the correct code is critical. Using a general upper endoscopy code when injection sclerotherapy has been performed constitutes undercoding and understates both the clinical complexity and the appropriate reimbursement. Conversely, applying G1440 to a diagnostic procedure only would constitute overcoding, which creates compliance risk for the practice. For a full overview of how CCSD codes work within UK private healthcare, see the Bupa CCSD codes guide.

CCSD Code G1440 Fee Schedule: UK Private Insurer Rates

Reimbursement rates for CCSD Code G1440 vary between insurers and between contract years. No single national fixed rate exists across all UK private medical insurers (PMI). The following information is drawn from publicly available fee schedules, and practices should always verify current rates directly with each insurer before invoicing.

The 2021 Guernsey schedule figure of £1,910.00 is the only publicly verified numerical rate identified for CCSD Code G1440 at the time of writing. It is cited here as a directional reference, not as a current UK mainland rate. Practices billing Bupa, AXA Health, or Allianz Care should consult their recognised specialist contracts or the insurer’s provider portal for the applicable rate in the current contract year.

Documentation Requirements for CCSD Code G1440 Claims

Incomplete documentation is the most common reason CCSD Code G1440 claims are queried or rejected. Insurers review claims for oesophageal sclerotherapy carefully because of the clinical complexity and the associated fee level. Billing teams need to ensure the clinical record supports every element of the code before submitting.

Essential Clinical Record Elements for CCSD Code G1440

• Confirmed clinical indication: The record must document oesophageal varices as the confirmed or suspected diagnosis, typically with reference to portal hypertension, liver cirrhosis, or an alternative cause of portal pressure elevation.
• Pre-procedure assessment: Evidence of haemodynamic status, recent haemoglobin or clotting screen results where clinically relevant, and any relevant risk stratification (e.g. Child-Pugh score for liver disease severity).
• Procedure note confirming endoscopic access: Documentation that upper GI endoscopy was performed, the oesophagus was visualised, and varices were identified at the specific location treated.
• Sclerosing agent used: Record the agent injected (e.g. polidocanol, ethanolamine oleate, sodium tetradecyl sulphate) and the volume per injection site.
• Number of injection sites: Document each site treated within the session.
• Post-procedure findings and plan: Record the immediate outcome, any complications, and the plan for follow-up or repeat endoscopy.
• Surgeon identification: The operating clinician must be the recognised specialist submitting the claim. Insurer recognition requirements apply.

Pre-Authorisation for CCSD Code G1440

Most UK private medical insurers require pre-authorisation for surgical and interventional procedures at this fee level. For CCSD Code G1440 in an elective or semi-elective setting, the treating clinician or their practice team should obtain written authorisation from the insurer before proceeding. Emergency presentations are handled differently: document that the procedure was performed as an emergency with clinical justification, then notify the insurer immediately after the episode and submit retrospective authorisation paperwork within the insurer’s specified timeframe.

Pabau’s claims management software allows UK private practices to track authorisation status against each patient episode, attach authorisation reference numbers directly to the claim, and flag cases where authorisation is pending before the invoice is submitted.

Manage CCSD Claims Without the Manual Chase

Pabau helps UK private practices track insurer authorisations, attach CCSD codes to patient records, and submit claims accurately the first time. See how it works for gastroenterology and surgical teams.

Book a demo

How to Bill CCSD Code G1440: Step-by-Step Workflow

Submitting a clean CCSD Code G1440 claim requires a sequenced workflow from clinical consent through to electronic submission. Errors at any stage create delays that affect cash flow and increase administrative overhead. The following workflow applies to most UK private insurer submission processes.

1. Confirm specialist recognition: Verify that the treating clinician is recognised by the relevant insurer for this specialty. Unrecognised specialists cannot submit claims directly to that insurer.
2. Obtain pre-authorisation: Contact the insurer before the elective procedure. Record the authorisation reference number in the patient’s clinical record and your practice management system.
3. Complete the procedure note at the time of treatment: Do not rely on dictation completed days later. Same-day or next-day documentation reduces the risk of missing clinical detail that insurers request on query.
4. Select CCSD Code G1440 on the invoice: Use the exact code without modification for injection sclerotherapy of oesophageal varices. If a separate diagnostic endoscopy was also performed in the same session, review the relevant CCSD bundling rules before adding a secondary code.
5. Attach all supporting documentation: Include the procedure note, anaesthetist details if applicable, and the pre-authorisation reference. Some insurers (particularly Bupa) require electronic submission via Healthcode or their specific portal.
6. Submit within the insurer’s time limit: Most UK private insurers require claims to be submitted within 3 to 6 months of the date of service. Late submission is grounds for non-payment regardless of clinical validity.
7. Monitor and follow up: Track the claim status actively. If the claim is queried, respond with the specific documentation requested rather than resubmitting the entire claim.

The CCSD Technical Guide (October 2025 edition) provides the authoritative reference for coding conventions and bundling principles. Practices should keep a copy accessible to billing staff, particularly when coding complex endoscopic episodes that involve multiple CCSD codes in a single session.

Related CCSD Codes for Oesophageal and Upper GI Procedures

Understanding where CCSD Code G1440 sits within the broader oesophageal and upper GI procedure coding structure helps billing teams avoid both undercoding and bundling errors. The following codes are commonly encountered alongside G1440 in gastroenterology and upper GI surgical practice.

When multiple oesophageal procedures are performed in a single session, always review the CCSD Technical Guide’s bundling rules before applying secondary codes. Some insurers, including Healix, publish explicit unbundling guidelines that specify which CCSD codes may be separately billed when performed together. The compliance management tools within Pabau’s platform help practices document which codes were applied and why, creating an auditable trail if an insurer queries a multi-code submission.

Insurer-Specific Notes for CCSD Code G1440 Claims

Each UK private medical insurer has specific requirements that go beyond the CCSD code itself. The following notes are drawn from publicly available insurer guidance and are intended to help billing teams anticipate insurer-specific requirements before submission.

Bupa CCSD Code G1440 Submissions

Bupa operates its own online code search portal at codes.bupa.co.uk, where recognised specialists can verify the current scheduled fee for G1440 under their contract. Bupa strongly encourages electronic submission via Healthcode. Paper claims and manual submissions increase processing time and the likelihood of queries. Specialist recognition with Bupa is a prerequisite: claims submitted by non-recognised specialists will be declined at the outset regardless of the clinical validity of the procedure.

AXA Health CCSD Code G1440 Submissions

AXA Health groups oesophageal procedures under Chapter 10 of its CCSD schedule. The AXA portal notes that the benefit for gastroscopy and sigmoidoscopy includes a sedation component. Billing teams should confirm whether sedation is bundled into the G1440 rate or requires a separate anaesthetist submission. Submit via the AXA Health specialist portal and verify that the treating specialist’s registration is current before each submission batch.

Allianz Care UK CCSD Code G1440 Submissions

Allianz Care UK publishes a comprehensive CCSD-coded national fee schedule, updated most recently in December 2024. This schedule is the reference point for all Allianz-insured patient claims. Access the current document via the Allianz Care UK provider resources page. Allianz requires pre-authorisation for elective interventional procedures. Confirm the authorisation number before the procedure date and include it on every invoice line related to that episode.

The Exeter CCSD Code G1440 Submissions

The Exeter publishes maximum benefit rates by CCSD code via its online fee schedule at dyn.the-exeter.com. The schedule states explicitly that maximum benefit payments do not prevent specialists from charging above those rates, but any excess becomes the patient’s responsibility. Practices should inform patients of this potential liability before the procedure. The client management tools in Pabau make it straightforward to record and share fee estimates with patients ahead of any interventional episode.

Expert Picks

Need a full overview of CCSD billing for Bupa-insured patients? Bupa CCSD Codes: Complete Guide for UK Clinics covers code lookup, common denial reasons, and electronic submission requirements in detail.

Managing claims across multiple UK private insurers? Pabau Claims Management Software supports CCSD-coded submission workflows, authorisation tracking, and claim status monitoring.

Looking to improve documentation standards across your gastroenterology or surgical team? Pabau Digital Forms allows you to build procedure-specific note templates that capture all insurer-required fields at point of care.

Conclusion

CCSD Code G1440 covers one of the more complex endoscopic interventions billed in UK private gastroenterology practice. Injection sclerotherapy for oesophageal varices carries a meaningful fee level and a correspondingly high standard of documentation and pre-authorisation. The practices that avoid claim delays are those that treat the billing workflow with the same rigour as the clinical pathway: confirmed recognition, documented indication, detailed procedure notes, and timely submission within each insurer’s window.

For UK private practices billing CCSD procedures across multiple insurers, Pabau’s claims management software centralises authorisation tracking, links CCSD codes to patient records, and reduces the manual overhead of multi-insurer submission. To see how Pabau supports gastroenterology and surgical billing teams, book a demo.

Frequently Asked Questions